FDA Approves Simplified Use of Bivalent mRNA COVID-19 Vaccines

FDA Approves Simplified Use of Bivalent mRNA COVID-19 Vaccines

The U.S. Food and Drug Administration has modified the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines, making the vaccination schedule simpler for most people. The revised EUAs authorize the use of the current bivalent vaccines (original and omicron BA.4/BA.5 strains) for all doses given ...

Read More »